Gefapixant (MK-7264)

Gefapixant · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gefapixant (MK-7264), covering 2020-11-19 to 2020-11-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of Gefapixant (MK-7264) in Participants With Obstructive Sleep Apnea (MK-7264-039) [Phase 1]

See pricing